Seasoned Research Scientist with a robust background at Wuxi AppTec and Thomas Jefferson University, specializing in CRISPR/Cas9 and data analytics. Demonstrated excellence in developing AAV vector therapies and leading FDA approval processes. Skilled in scientific writing and client management, with a proven track record of pioneering research methods and driving innovation in drug discovery.